EUVIMEDSkopri EUVIMED
Open access

Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning

Jonas B Nilsson iD, Saghar Kaabinejadian iD, Hooman Yari iD, Michel G D Kester iD, Peter van Balen iD, William H Hildebrand iD, Morten Nielsen iD

Science Advances · 2023-11-24 · 9 (47)

DOI: 10.1126/sciadv.adj6367 ↗

At a glance

Journal article in Science Advances, published on 2023-11-24. Written by Jonas B Nilsson and 6 co-authors. Institution: Department of Health Technology, Technical University of Denmark, DK-2800 Lyngby, Denmark. Major MEDLINE topics: Antigen Presentation, HLA-DR Antigens. Cited 215 times so far (Crossref); 57 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NCI NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Accurate prediction of antigen presentation by human leukocyte antigen (HLA) class II molecules is crucial for rational development of immunotherapies and vaccines targeting CD4 + T cell activation. So far, most prediction methods for HLA class II antigen presentation have focused on HLA-DR because of limited availability of immunopeptidomics data for HLA-DQ and HLA-DP while not taking into account alternative peptide binding modes. We present an update to the NetMHCIIpan prediction method, which closes the performance gap between all three HLA class II loci. We accomplish this by first integrating large immunopeptidomics datasets describing the HLA class II specificity space across all loci using a refined machine learning framework that accommodates inverted peptide binders. Next, we apply targeted immunopeptidomics assays to generate data that covers additional HLA-DP specificities. The final method, NetMHCIIpan-4.3, achieves high accuracy and molecular coverage across all HLA class II allotypes .

Subjects

MeSH terms (MEDLINE)

Antigen PresentationHLA-DR AntigensHumansHLA-DP AntigensHLA-DQ AntigensPeptides

Substances

HLA-DR AntigensHLA-DP AntigensHLA-DQ AntigensPeptides

Authors and institutions

  • Department of Health Technology, Technical University of Denmark, DK-2800 Lyngby, Denmark.
  • Pure MHC LLC, Oklahoma City, OK, USA.
  • Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

ORCID profiles: Jonas B Nilsson, Saghar Kaabinejadian, Hooman Yari, Michel G D Kester, Peter van Balen, William H Hildebrand, Morten Nielsen

Funding

  • NIAID NIH HHS
  • NCI NIH HHS

Cite

APA

Nilsson, J. B., Kaabinejadian, S., Yari, H., Kester, M. G. D., van Balen, P., Hildebrand, W. H., & Nielsen, M. (2023). Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Science Advances, 9(47). https://doi.org/10.1126/sciadv.adj6367

Vancouver

Nilsson JB, Kaabinejadian S, Yari H, Kester MGD, van Balen P, Hildebrand WH, et al. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Science Advances. 2023;9(47). doi:10.1126/sciadv.adj6367

BibTeX
@article{Nilsson2023,
  author = {Nilsson, Jonas B and Kaabinejadian, Saghar and Yari, Hooman and Kester, Michel G D and van Balen, Peter and Hildebrand, William H and Nielsen, Morten},
  title = {Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {47},
  doi = {10.1126/sciadv.adj6367}
}
Start for free →